The first incretin approved by the FDA in May 2005 was Byetta (exenatide)
However, for those considering body contouring or other cosmetic procedures at Center for SmartLipo & Plastic Surgery, the decision to continue or discontinue treatment should be carefully evaluated in consultation with your healthcare provider and our experienced team
Coskun T, Urva S, Roell WC et al (2022) LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept
use only with close monitoring) Musculoskeletal: Mild weakness: Described only with D,L-carnitine in uremic patients
Strategies for supporting skin elasticity during weight loss, including adequate protein intake, hydration, and collagen supplementation, can help but do not eliminate the issue entirely for everyone